Mechanistic Multiscale Pharmacokinetic Model for the Anticancer Drug 2',2'‐difluorodeoxycytidine (Gemcitabine) in Pancreatic Cancer
The aim of this work is to build a mechanistic multiscale pharmacokinetic model for the anticancer drug 2',2'‐difluorodeoxycytidine (gemcitabine, dFdC), able to describe the concentrations of dFdC metabolites in the pancreatic tumor tissue in dependence of physiological and genetic patient...
Saved in:
Main Authors: | Maria Garcia‐Cremades (Author), Nicola Melillo (Author), Iñaki F. Troconiz (Author), Paolo Magni (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gemcitabine Combination Nano Therapies for Pancreatic Cancer
by: Kamalika Samanta, et al.
Published: (2019) -
QSP‐IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno‐Oncology Applications
by: Richard J. Sové, et al.
Published: (2020) -
A physiologically based pharmacokinetic model for V937 oncolytic virus in mice
by: Sara Peribañez-Dominguez, et al.
Published: (2023) -
Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells
by: Xu Zhu, et al.
Published: (2018) -
Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells
by: Tormod Bjånes, et al.
Published: (2020)